4.99

1.77% -0.09

Olema Pharmaceuticals Inc (OLMA)

Overview News Price History Option Chain Financials Discussions Forecast

Olema Pharmaceuticals Inc stock is traded at $4.99, with a volume of 503.18K. It is down -1.77% in the last 24 hours and down -9.27% over the past month. Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

Previous Close:

$5.08

Open:

$5.15

24h Volume:

503.18K

Relative Volume:

0.48

Market Cap:

$370.48M

Revenue:

Net Income/Loss:

$-96.66M

P/E Ratio:

-2.3209

EPS:

-2.15

Net Cash Flow:

$-83.73M

1W Performance:

+0.40%

1M Performance:

-9.27%

6M Performance:

-59.76%

1Y Performance:

-64.02%

1-Day Range:

$4.94

$5.21

1-Week Range:

$4.935

$5.34

52-Week Range:

$4.60

$16.62

Olema Pharmaceuticals Inc Stock (OLMA) Company Profile

Name

Olema Pharmaceuticals Inc

Sector

Healthcare (1169)

Industry

Biotechnology (678)

Phone

(415) 651-3316

Address

780 BRANNAN STREET, SAN FRANCISCO

Employee

Twitter

Next Earnings Date

2024-11-05

Latest SEC Filings

OLMA's Discussions on Twitter

Compare OLMA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
OLMA Olema Pharmaceuticals Inc	4.99	370.48M	0	-96.66M	-83.73M	-2.15
VRTX Vertex Pharmaceuticals Inc	484.24	124.35B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	700.33	76.56B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	644.48	39.16B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	250.59	32.44B	2.25B	-278.16M	-42.59M	-2.17
BNTX Biontech Se Adr	120.01	28.77B	3.30B	-501.07M	1.03B	-2.1146

Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-02-24	Initiated	Goldman	Buy
Jan-30-24	Initiated	Citigroup	Buy
Jul-21-23	Initiated	Oppenheimer	Outperform
May-05-23	Initiated	CapitalOne	Overweight
Feb-22-23	Initiated	Credit Suisse	Outperform
Jul-06-22	Resumed	Canaccord Genuity	Buy
Jun-09-22	Upgrade	H.C. Wainwright	Neutral → Buy
Feb-28-22	Initiated	H.C. Wainwright	Neutral
Dec-07-21	Resumed	Cowen	Outperform
Dec-14-20	Initiated	Canaccord Genuity	Buy
Dec-14-20	Initiated	Cowen	Outperform
Dec-14-20	Initiated	JP Morgan	Overweight
Dec-14-20	Initiated	Jefferies	Buy

View All

Olema Pharmaceuticals Inc Stock (OLMA) Latest News

Feb 20, 2025

Olema Oncology to Present at the TD Cowen 45th Annual Health Care Conference - GlobeNewswire

Feb 20, 2025

Feb 19, 2025

Can Olema's Breast Cancer Breakthrough Transform Patient Care? CEO Reveals Latest Data - StockTitan

Feb 19, 2025

Feb 18, 2025

Mehta named CMO, Greenberg CBO at Nura Bio - BioCentury

Feb 18, 2025

Olema Oncology Appoints Shawnte M. Mitchell, J.D. as Chief Legal Officer and Corporate Secretary - GlobeNewswire

Feb 18, 2025

Key Executive Hire: Biotech Veteran with 20-Year Track Record Joins Olema's C-Suite - StockTitan

Feb 18, 2025

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Sees Large Decrease in Short Interest - MarketBeat

Feb 18, 2025

Feb 17, 2025

Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Down 5.4%Should You Sell? - MarketBeat

Feb 17, 2025

Feb 16, 2025

Olema Pharmaceuticals: Interesting But Undifferentiated Data (NASDAQ:OLMA) - Seeking Alpha

Feb 16, 2025

Feb 13, 2025

Olema Pharmaceuticals Inc (NASDAQ: OLMA) Slashes -5.36%: What Could Be On The Way Going Forward? - Stocks Register

Feb 13, 2025

SG Americas Securities LLC Has $102,000 Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

Feb 13, 2025

Feb 11, 2025

OLMA’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle

Feb 11, 2025

Feb 10, 2025

Upward Trajectory: Olema Pharmaceuticals Inc (OLMA) Posts a Slidee, Closing at 5.69 - The Dwinnex

Feb 10, 2025

Feb 07, 2025

The Significance of Moving Averages in Olema Pharmaceuticals Inc Inc. (OLMA) Price Performance - The InvestChronicle

Feb 07, 2025

Feb 06, 2025

There is no way Olema Pharmaceuticals Inc (OLMA) can keep these numbers up - SETE News

Feb 06, 2025

Feb 04, 2025

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Feb 04, 2025

OLMAOlema Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan

Feb 04, 2025

Olema Pharma's Strategic Talent Acquisition: $1.7M in Equity Grants Signals Growth Push - StockTitan

Feb 04, 2025